日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

N α -acetyl-L-ornithine deacetylase from Escherichia coli and a ninhydrin-based assay to enable inhibitor identification

大肠杆菌的 N α -乙酰-L-鸟氨酸脱乙酰酶和基于茚三酮的检测方法用于鉴定抑制剂

Emma H Kelley, Jerzy Osipiuk, Malgorzata Korbas, Michael Endres, Alayna Bland, Victoria Ehrman, Andrzej Joachimiak, Kenneth W Olsen, Daniel P Becker

In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity

2-氨基环丁酮与 SARS-CoV-2 Nsp13 解旋酶的计算机结合及抗病毒活性的证明

Thahani S Habeeb Mohammad, Yash Gupta, Cory T Reidl, Vlad Nicolaescu, Haley Gula, Ravi Durvasula, Prakasha Kempaiah, Daniel P Becker

Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry

含碳硼烷的羟肟酸 MMP 配体用于硼中子俘获疗法 (BNCT) 治疗肿瘤:无需进入肿瘤细胞即可获得疗效

Sebastian Flieger, Mao Takagaki, Natsuko Kondo, Marlon R Lutz Jr, Yash Gupta, Hiroki Ueda, Yoshinori Sakurai, Graham Moran, Prakasha Kempaiah, Narayan Hosmane, Minoru Suzuki, Daniel P Becker

Repurposing Lansoprazole and Posaconazole to treat leishmaniasis: Integration of in vitro testing, pharmacological corroboration, and mechanisms of action

重新利用兰索拉唑和泊沙康唑治疗利什曼病:体外试验、药理学确证和作用机制的整合

Yash Gupta, Steven Goicoechea, Jesus G Romero, Raman Mathur, Thomas R Caulfield, Daniel P Becker, Ravi Durvasula, Prakasha Kempaiah

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

双吲哚马来酰亚胺 IX:一种针对病毒主蛋白酶 3CLpro 的新型抗 SARS-CoV2 药物,通过虚拟筛选流程和体外验证试验证明

Yash Gupta, Dawid Maciorowski, Samantha E Zak, Krysten A Jones, Rahul S Kathayat, Saara-Anne Azizi, Raman Mathur, Catherine M Pearce, David J Ilc, Hamza Husein, Andrew S Herbert, Ajay Bharti, Brijesh Rathi, Ravi Durvasula, Daniel P Becker, Bryan C Dickinson, John M Dye, Prakasha Kempaiah

Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease

口服活性 MMP-1 保留 α-四氢吡喃基和 α-哌啶基砜基质金属蛋白酶 (MMP) 抑制剂,可有效治疗癌症、关节炎和心血管疾病

Daniel P Becker, Thomas E Barta, Louis J Bedell, Terri L Boehm, Brian R Bond, Jeffery Carroll, Chris P Carron, Gary A Decrescenzo, Alan M Easton, John N Freskos, Chris L Funckes-Shippy, Marcia Heron, Susan Hockerman, Carol Pearcy Howard, James R Kiefer, Madeleine H Li, Karl J Mathis, Joseph J McDona